Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Scientific Reports|August 18, 2025
Callerya Atropurpurea shells derived nitrogen doped carbon quantum dots of electrodes for symmetrical and asymmetrical supercapacitorsAbdulrahman Oyekanmi Adeleke, Mohd Arif Dar, Temitope T Dele-Afolabi, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|February 6, 2016
A randomised trial of placing preterm infants on their back or left side after birthEmily Stenke, Emily A Kieran, Lisa K McCarthy, et al.
Resuscitation|July 14, 2018
Respiratory changes in term infants immediately after birthDouglas A Blank, Vincent D Gaertner, C Omar F Kamlin, et al.
Resuscitation|July 24, 2018
Baby-directed umbilical cord clamping: A feasibility studyDouglas A Blank, Shiraz Badurdeen, C Omar F Kamlin, et al.
Trials|November 7, 2023
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trialKate L Francis, Christopher J D McKinlay, C Omar F Kamlin, et al.
Plos Medicine|June 23, 2022
Physiologically based cord clamping for infants ≥32+0 weeks gestation: A randomised clinical trial and reference percentiles for heart rate and oxygen saturation for infants ≥35+0 weeks gestationShiraz Badurdeen, Peter G Davis, Stuart B Hooper, et al.
Trials|May 10, 2023
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trialBrett J Manley, C Omar F Kamlin, Susan Donath, et al.
World Journal of Surgery|January 7, 2015
Surgical Care and Health SystemsDavid A Spiegel, Mohit Misra, Peter Bendix, et al.
JHEP Reports : Innovation in Hepatology|March 14, 2026
Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson diseasePeter Ott, Thomas Sandahl, Aftab Ala, et al.
The Lancet. Gastroenterology & Hepatology|October 2, 2022
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trialMichael L Schilsky, Anna Czlonkowska, Massimo Zuin, et al.
Pageof 9